Teladoc Health, Inc. TDOC 深 滬
等待開盤 04-02 09:30:00 美东时间
5.28
-0.170
-3.12%
華盛通- 最 高5.59
- 今 開5.52
- 成交量 490.12万股
- 最 低 5.26
- 昨 收 5.45
- 總市值 9.42亿
- 52周最高 9.77
- 市盈率 靜 --
- 換手率 2.75%
- 52周最低 4.40
- 委 比 25.65%
- 總股本 1.78亿
- 歷史最高 308.00
- 量 比 1.00
- 振 幅 6.06%
- 歷史最低 4.40
- 每 手 1
- 風險率 1.10%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Teladoc Faces Pressure Over Capital Allocation And Stock Underperformance
Pineal Capital urges Teladoc to boost buybacks, cut costs, and review strategy amid concerns over valuation and takeover risk.
今天 00:00
Stocks to watch on Tuesday after market: RH, NKE, TDOC
Wall Street’s major market averages ended higher on Tuesday as an end to the Iran conflict could be near, with President Donald Trump prepared to wind down the military campaign against the country wi...
04-01 05:46
Teladoc rises following appointment of new board member, investor letter
Teladoc Health closed Tuesday up 6%, a day after it had announced after Monday's closing bell the appointment of Susan Salka to its board. Salka is the former CEO of healthcare workforce technology so...
04-01 05:39
Teladoc Adds Susan Salka to Expanded Board of Directors
Teladoc ( ($TDOC) ) has provided an announcement. On March 30, 2026, Teladoc He...
03-31 07:27
美股大行评级 | 大摩、高盛上调Denali Therapeutics目标价；Chewy、沛齐遭多家大行下调目标价
今日重点评级关注：HC Wainwright & Co.：维持Atossa Therapeutics"买入"评级，目标价从7美元升至25美元；Needham：维持Nkarta"买入"评级，目标价从10美元升至11美元
03-27 10:22
Barclays Maintains Equal-Weight on Teladoc Health, Lowers Price Target to $7
Barclays analyst Glen Santangelo maintains Teladoc Health (NYSE:TDOC) with a Equal-Weight and lowers the price target from $8.5 to $7.
03-26 20:47
美股大行评级 | 韦德布什升美光科技目标价升至500美元，维持"跑赢大市"评级
今日重点评级关注：Piper Sandler：维持Allogene疗法"超配"评级，目标价从7美元升至8美元；B. Riley证券：维持Oncology Institute"买入"评级，目标价从6美元升至8美元
03-16 18:19
美股大行评级 | 潜在涨幅467.73%！Corbus制药控股获Oppenheimer升目标价至57美元，维持"跑赢大市"评级
今日重点评级关注：Oppenheimer：维持Corbus制药控股"跑赢大市"评级，目标价从53美元升至57美元；Canaccord Genuity：维持WAVE Life Sciences"买入"评级，目标价从43美元升至52美元
03-11 12:40
Deutsche Bank Upgrades Teladoc Health to Buy, Announces $11 Price Target
Deutsche Bank analyst George Hill upgrades Teladoc Health (NYSE:TDOC) from Hold to Buy and announces $11 price target.
03-10 23:47
Teladoc Health Stock Pops - Here's Why
Teladoc Health stock jumps after beating earnings estimates, even as cautious 2026 guidance and mixed analyst views emerge.
03-10 22:49
